CYTOAURORA BIOTECHNOLOGIES, INC.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
The blood detection chip developed by CytoAurora is based on Taiwan's semiconductor technology, combined with self-developed artificial intelligence software, and integrated molecular pathology technology to develop a world-leading cancer detection equipm
Founded Year
2015
Unified Business No.
42579799
Status
Active
Number of Employees
0
Total Paid-in
Capital
88,018,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Overseas Development
France、Japan、Thailand
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Established in 2015, CytoAurora Biotechnology actively promotes cross-field integration, hoping to introduce the biotechnology and medical industry with the advantages of Taiwan's semiconductor and electronics industries, and is committed to the research and development of innovative cell biotechnology and equipment, which can be applied to gene and protein research. Aim at the research and development in the field of precision medicine, provide more accurate medical services, and give back to the society.
